STABLE ORAL AVAILABILITY OF SUSTAINED-RELEASE PROPRANOLOL WHEN CO-ADMINISTERED WITH HYDRALAZINE OR FOOD - EVIDENCE IMPLICATING SUBSTRATE DELIVERY RATE AS A DETERMINANT OF PRESYSTEMIC DRUG-INTERACTIONS

被引:26
作者
BYRNE, AJ
MCNEIL, JJ
HARRISON, PM
LOUIS, W
TONKIN, AM
MCLEAN, AJ
机构
[1] BAKER MED RES INST,CLIN PHARMACOL LAB,PRAHRAN,VIC 3181,AUSTRALIA
[2] UNIV MELBOURNE,AUSTIN HOSP,DEPT MED,CLIN PHARMACOL UNIT,HEIDELBERG,VIC 3084,AUSTRALIA
关键词
D O I
10.1111/j.1365-2125.1984.tb02427.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:S45 / S50
页数:6
相关论文
共 17 条
[1]   PHARMACOKINETICS OF PROPRANOLOL [J].
BORGSTROM, L ;
JOHANSSON, CG ;
LARSSON, H ;
LENANDER, R .
JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS, 1981, 9 (04) :419-429
[2]  
DAVIES R, 1978, LANCET, V1, P407
[3]  
DRUMMER DH, 1981, J PHARM SCI, V70, P1031
[4]   PHARMACOKINETICS OF PROPRANOLOL IN NORMAL HEALTHY VOLUNTEERS [J].
GOMENI, R ;
BIANCHETTI, G ;
SEGA, R ;
MORSELLI, PL .
JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS, 1977, 5 (03) :183-192
[5]   THE EFFECT OF HYDRALAZINE ON THE PHARMACOKINETICS OF THREE DIFFERENT BETA-ADRENOCEPTOR ANTAGONISTS - METOPROLOL, NADOLOL, AND ACEBUTOLOL [J].
JACK, DB ;
KENDALL, MJ ;
DEAN, S ;
LAUGHER, SJ ;
ZAMAN, R ;
TENNESON, ME .
BIOPHARMACEUTICS & DRUG DISPOSITION, 1982, 3 (01) :47-54
[6]  
LIEDHOLM H, 1983, DRUG NUTR INTERACT, V1, P293
[7]  
MACKICHAN JJ, 1978, RES COMMUN CHEM PATH, V20, P531
[8]   INTERACTION BETWEEN ORAL PROPRANOLOL AND HYDRALAZINE [J].
MCLEAN, AJ ;
SKEWS, H ;
BOBIK, A ;
DUDLEY, FJ .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1980, 27 (06) :726-732
[9]   REDUCTION OF 1ST-PASS HEPATIC-CLEARANCE OF PROPRANOLOL BY FOOD [J].
MCLEAN, AJ ;
ISBISTER, C ;
BOBIK, A ;
DUDLEY, FJ .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1981, 30 (01) :31-34
[10]  
MCLEAN AJ, 1978, CLIN PHARMACOL THER, V24, P5